News

OrthoMimetics, the first technology spin-out from the Cambridge-MIT Institute, Cambridge, UK, has begun its search for initial funding.

A new proposal from the European Investment Fund seeks to accelerate the success of European technology transfer projects. A noble idea, says Mary Lisbeth D'Amico in her fortnightly column, but no one has yet stepped up to foot the bill.

New regulations on the registration and testing of chemicals could have some problematic knock-on effects on European R&D – but they could also bring some lucrative work the way of contract research organisations.

With licensing and collaboration now the lifeblood of the drug industry, the annual BIO-Europe get-together was focused on partnering. Nuala Moran was there.

Better, brighter, faster – that's where photonic lasers are trying to take us. A lay guide to the technology.

Some strange new ways of raising money are starting to emerge - but would-be borrowers and lenders are still making sense of them.

On the glut of patenting, BASF's rising research budget, football fever in the Commons, and other insights into R&D management

The pace of forming academic spin-out companies picked up in the US in 2004 after a two-year slump, according to a survey released today.